Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 5
Submit an article Journal homepage
399
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL

Mareike FrickDepartment of Hematology, Oncology and Tumor Immunology, and Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Berlin, Germany; ;Berlin Institute of Health (BIH), BIH Biomedical Innovation Academy, Berlin, Germany; Correspondence[email protected]
View further author information
,
Marcus BettstetterMolekularpathologie Südbayern, Munich, Germany; View further author information
,
Simone BertzInstitute of Pathology, University Hospital Erlangen, Erlangen, Germany; View further author information
,
Stephan Schwarz-FurlanInstitute of Pathology, University Hospital Erlangen, Erlangen, Germany; ;Institute of Pathology, Klinikum Kaufbeuren, Kaufbeuren, Germany; View further author information
,
Arndt HartmannInstitute of Pathology, University Hospital Erlangen, Erlangen, Germany; View further author information
,
Thomas RichterInstitute of Pathology, Rosenheim, Germany; View further author information
,
Dido LenzeDepartment of Pathology, Charité-Universitätsmedizin, Berlin, Germany; View further author information
,
Michael HummelDepartment of Pathology, Charité-Universitätsmedizin, Berlin, Germany; View further author information
,
Martin DreylingDepartment of Internal Medicine III, University Hospital Munich, Munich, Germany; View further author information
,
Georg LenzTranslational Oncology, Department of Medicine A, University Hospital Münster, Münster, Germany; ;Cluster of Excellence EXC 1003, Cells in Motion, Münster, GermanyView further author information
&
Andreas GaumannInstitute of Pathology, Klinikum Kaufbeuren, Kaufbeuren, Germany; View further author information
 show all
Pages 1260-1263 | Received 23 Dec 2016, Accepted 13 Aug 2017, Published online: 03 Sep 2017

References

  • Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–2390.
  • Nogai H, Dorken B, Lenz G. Pathogenesis of non-Hodgkin’s lymphoma. J Clin Oncol. 2011;29:1803–1811.
  • Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937–1947.
  • Lenz G, Wright G, Dave SS, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008;359:2313–2323.
  • Davis RE, Brown KD, Siebenlist U, et al. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med. 2001;194:1861–1874.
  • Davis RE, Ngo VN, Lenz G, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 2010;463:88–92.
  • Ngo VN, Young RM, Schmitz R, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature. 2011;470:115–119.
  • Chapuy B, Roemer MG, Stewart C, et al. Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood. 2015;127:869–881.
  • Kraan W, van Keimpema M, Horlings HM, et al. High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma. Leukemia. 2014;28:719–720.
  • Nakamura T, Tateishi K, Niwa T, et al. Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas. Neuropathol Appl Neurobiol. 2015;42:279–290.
  • Yamada S, Ishida Y, Matsuno A, et al. Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations. Leuk Lymphoma. 2015;56:2141–2145.
  • Bruno A, Boisselier B, Labreche K, et al. Mutational analysis of primary central nervous system lymphoma. Oncotarget. 2014;5:5065–5075.
  • Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–282.
  • Kraan W, Horlings HM, van Keimpema M, et al. High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites. Blood Cancer J. 2013;3:e139.
  • Skacel M, Paris PL, Pettay JD, et al. Diffuse large B-cell lymphoma of the stomach: assessment of microsatellite instability, allelic imbalance, and trisomy of chromosomes 3, 12, and 18. Diagn Mol Pathol: Am J Surg Pathol B. 2002;11:75–82.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.